Compound ID | 2225
Class: Glycopeptide
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Interferes with cell wall turnover by indirectly inhibiting autolysins |
| Target Pathogen: | Active against Staphylococcus aureus, Bacillus subtilis, Enterococcus faecium, and Streptomyces sp. |
| Description: | Natural product from Streptomyces sp.; discovered through GPAHex platform - cryptic BGC but cloned and expressed in Streptomyces sp.; a type V glycopeptide |
| Year first mentioned: | 2020 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/169492460 |
| Citation: | https://www.nature.com/articles/s41467-020-19138-5#Sec2 |